$BHVN 3 SEC Filings

Filed On	Filing
14 Aug 2026	Form 3: Yetimoglu John, Director Holds 6,250,000 shares of Common Shares
17 Jul 2026	Form 3: Volles Warren Karl, Chief Legal Officer Holds 248,212 shares of Common Shares
18 Nov 2022	Form 3: Clark George C., VP, Chief Accounting Officer Holds 61,285 shares of Common Shares
05 Oct 2022	Form 3: Car Bruce, Chief Scientific Officer No securities owned
30 Sep 2022	Form 3: Hugin Robert J, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Heffernan Michael Thomas, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Bailey Gregory, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Mehta Kishan, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Gentile Kimberly, SVP, Clinical Operations Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Childs John W, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Gregory Julia P, Director Holds 0 shares of No Securities Owned
30 Sep 2022	Form 3: Antonijevic Irina, Director Holds 0 shares of No Securities Owned
28 Sep 2022	Form 3: Coric Vlad, Director Holds 0 shares of No Securities Owned
28 Sep 2022	Form 3: Buten Matthew, Treasurer Holds 0 shares of No Securities Owned
28 Sep 2022	Form 3: Biohaven Pharmaceutical Holding Co Ltd., 10% owner Holds 100 shares of Common Shares

Comments